Navonil DS (@Navonilde) header
Navonil DS (@Navonilde) profile picture

(Pronouns He/Him). DAD/Husband/Scientist @ProstateCancer @CancerGenomics @Biomarker_Research @Mountain_Lover @DNA repair @Signature 'tweet are mine'

Seattle, WA
Joined May 2009
Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)Photo by Navonil DS (@Navonilde)
ATM rarely confers sensitivity to PARPi. But it does confer sensitivity to TOPO1 inhibitors. 👉🔥🎯 link.springer.com/article/10…
1
11
48
1,922
The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most. For 33 years, PCF has brought science and lived experience together to move research forward. #PCFRetreat26
3
20
1
55
2,656
Delighted that he is joining precision/rare/phase 1
Happy to Join MCW Cancer Center as Assistant Professor and Medical Oncologist - Yu Fujiwara @waraonc23jp oncodaily.com/career/yu-fuji…
2
18
3,097
I’m excited to launch Science in GU Oncology, a new monthly newsletter in partnership with @urotoday Each issue will cover the latest scientific advances in GU cancers and what they mean for patient care. bit.ly/4bMIfPn
3
25
77
4,979
One diagnosis sparked a movement. 💙 After being diagnosed with advanced prostate cancer, Michael Milken founded the Prostate Cancer Foundation. His mission: accelerate research and improve outcomes for patients everywhere. More than 30 years later, that mission remains true.
2
6
605
The Center for Precision Oncology and Rare Cancers/Precision Medicine and Rare Cancer Clinic at MCW could not function without our pharmacists pubmed.ncbi.nlm.nih.gov/4245…
4
17
1,504
Navonil DS retweeted
Now online: Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS -Mutant Cholangiocarcinoma doi.org/10.1158/2159-8290.CD…
1
7
1
14
2,440
Navonil DS retweeted
Now online: Germline CDK12 variants in aggressive prostate cancer doi.org/10.1158/2159-8290.CD…
6
2
9
8,861
Hope changes everything. At its heart, the Michels’ $27 million gift to MCW’s Center for Cancer Discovery is about the families facing a cancer diagnosis today—and those who will face one tomorrow. By investing in groundbreaking research, Tim and Barbara Michels are helping bring new hope, new possibilities, and new pathways to better outcomes for patients everywhere.
1
1
5
659
As we close out #WomensHistoryMonth, we honor the women of PCF whose leadership is helping shape the future of prostate cancer. Their voices, and women’s voices everywhere, spark conversations that lead to early detection and save lives. 💙
1
2
16
572
If you or a loved one has prostate cancer, germline genetic and somatic testing can open doors—to better treatment options, clinical trials, and a clearer picture of your family's cancer risk. Medical oncologist Dr. @EHeath4100 walks you through: bit.ly/47wv4Qt #MedEd
7
1
8
672
FUO 2026 applications are open! Senior urology residents (PGY3 in Aug 2026) are invited to join the inaugural SUO Future Urologic Oncologists program in Indianapolis (July 24–26) for mentorship, education, and networking with leaders in urologic oncology. Apply by April 20!
1
12
17
4,443
Join us in ending the stigma of getting tested for prostate cancer – early detection can save lives. Get a simple PSA blood test. Check the Box!
2
6
703
Thrilled to share the latest from @gungulati and team in collab with #MattFreedman. #LiquidBiopsy can reveal gene expression in cancer by integrating circulating histone mods and cfDNA fragmentation patterns. Excited to see how this expands the reach of precision oncology!
We infer earthquakes from distant vibrations and stars from photons emitted light-years away. Can we reconstruct a patient’s tumor biology from the signals it sheds into blood? Introducing APEX (Associating Plasma Epigenomics with eXpression), our framework for inferring cancer expression from plasma. Preprint: biorxiv.org/content/10.64898… @biorxivpreprint @DanaFarber @DrChoueiri @SylvanBacaLab #FreedmanLab
7
28
4,805
RFA for SUO Fellows & YUO Members! Apply by March 1, 2026 for up to $25,000 to develop innovative, patient-centered clinical trial concepts in urologic oncology. Funding & mentorship from SUO leaders. Apply here: bit.ly/46NmtII
6
3
1,751